(NYSE:APO), NEW YORK, Jan. 06, 2026 (GLOBE NEWSWIRE) — Apollo (NYSE: APO) plans to release financial results for the fourth quarter and full year 2025 on Monday, February 9, 2026, before the opening of trading on the New York Stock Exchange. Management will review Apollo's financial results at 8:30 am ET via public webcast available […]

(NasdaqGM:WLFC), COCONUT CREEK, Fla., Jan. 06, 2026 (GLOBE NEWSWIRE) — Willis Lease Finance Corporation (NASDAQ: WLFC) (“WLFC” or the “Company”), the leading lessor of commercial aircraft engines and a global provider of aviation services, today announced the establishment of Willis Aviation Capital (“WAC”), a new division that will focus on the management of third-party assets

(CNSX:HG.CN),(OTC US:HGRAF),(Other OTC:HGRAF),(Frankfurt:M98), MANCHESTER, United Kingdom, Jan. 06, 2026 (GLOBE NEWSWIRE) — HydroGraph Clean Power Inc. (CSE: HG) (OTCQB: HGRAF) (“HydroGraph” or the “Company”) and the Graphene Engineering Innovation Centre (GEIC) at The University of Manchester are expanding their collaboration as HydroGraph moves from a Tier 2 to a Tier 1 member. This milestone builds

(NASDAQ:TSHA), First patient dosed in REVEAL pivotal trial evaluating TSHA-102 (N=15, aged 6 to <22 years) in Q4 2025, with enrollment advancing across multiple sites Reached written alignment with FDA on inclusion of greater-than or equal to3 months of safety data from ASPIRE trial evaluating TSHA-102 (N=3, aged 2 to <4 years) in planned BLA

(CNSX:MAXM.CN),(Boerse Frankfurt – Freiverkehr:R7V), VANCOUVER, British Columbia, Jan. 06, 2026 (GLOBE NEWSWIRE) — Maxus Mining Inc. (“Maxus” or the “Company”) (CSE: MAXM | FRA: R7V), is pleased to provide highlights from a historical data compilation at the Quarry Project (the “Project” or the “Property“), located in the prolific Bralorne Mining District in British Columbia (Please

(NASDAQ:CGON), IRVINE, Calif., Jan. 06, 2026 (GLOBE NEWSWIRE) — CG Oncology, Inc. (NASDAQ: CGON), a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients with bladder cancer, today announced that Arthur Kuan, Chairman & Chief Executive Officer, and Ambaw Bellete, President & Chief Operating Officer, will present at

(NASDAQ:COGT), WALTHAM, Mass. and BOULDER, Colo., Jan. 06, 2026 (GLOBE NEWSWIRE) — Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced that Andrew Robbins, President and Chief Executive Officer, will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco on Tuesday, January

Mississauga, ON, Jan. 06, 2026 (GLOBE NEWSWIRE) — EllisDon announced an enhancement of its safety requirements, as of January 1st, 2026, all personnel, including subcontractors and visitors, on EllisDon worksites must wear a CSA and/or ANSI Type 2 hard hat with a manufacturer-approved integrated (four-point) chin strap, properly adjusted and fastened. The hard hat Class must be appropriate for the hazards present and compliant

FORT LAUDERDALE, Fla. and WEST DES MOINES, Iowa, Jan. 06, 2026 (GLOBE NEWSWIRE) — Syncromune(R) Inc., a clinical-stage biopharmaceutical company dedicated to the development of SYNC-T(TM), an in situ platform combination immunotherapy optimized for solid tumor cancers, today announced the appointment of Stephen P. Dale, M.D., as Chief Medical Officer. “Our priority at Syncromune is

(NASDAQ:HNRG), TERRE HAUTE, Ind., Jan. 06, 2026 (GLOBE NEWSWIRE) — Hallador Energy Company (Nasdaq: HNRG) (“Hallador” or the “Company”) today announced that its Board of Directors (the “Board”) has appointed Barbara Sugg to the Board, effective January 1, 2026. Ms. Sugg's appointment follows the resignation of David Hardie from the Board, effective January 1, 2026.